Comparative Study
Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Prospective studies on applications of a two-cuff Swan neck catheter and a Tenckhoff catheter to Chinese CAPD patients.

Clinical Nephrology 2009 November
AIM: To compare the difference of clinical curative effects of continuous ambulant peritoneal dialysis (CAPD) patients in China by using a two-cuff Swan neck catheter and a Tenckhoff catheter.

METHODS: 110 patients with end-stage renal disease (ESRD) were enrolled. They were divided into Group A (Swan neck catheter group, n = 55) and Group B (Tenckhoff catheter group, n = 55). One-year follow-up visits were made and information was recorded. Survival analysis was made by adopting the Kaplan-Meier method.

RESULTS: After 12 month follow-up visits, 17 patients had died, 3 had been transferred to renal transplantation, 8 had been transferred to hemodialysis, 3 were transferred to other hospitals, and the remaining 79 patients (71.8%) continued their peritoneal dialysis therapy in our hospital. 26 patients in both groups had peritonitis, with a total of 35 occurrences taking place. The total incidence of peritonitis was 0.32 times/patient year, with the detailed figure of 0.35 times/patient year for Group A and 0.29 times/patient year for Group B respectively (p > 0.05). Regarding mechanical complications of the 2 groups concerned, including catheter tip migration, Omental enwrapment, peritoneal dialysate leakage, skid of outer cuff, incidence of inguinal hernia and bellyache, etc, no significant difference existed between two groups (p > 0.05). The two groups had the same 12-month technical survival rate of 92.73%. The 12-month survival rate for Group A was 86.34% while the corresponding figure for Group B was 80.68% (p > 0.05).

CONCLUSIONS: Infections, mechanical complications, technical survival rate and patients' survival rate were quite similar, when a Swan neck catheter and a Tenckhoff catheter were used in Chinese CAPD patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app